Griffith University’s Institute for Glycomics has received a $5 million philanthropic donation from the International Leducq Foundation to further the development of a Strep A vaccine.
Cutting-edge dental technology may accelerate healing after procedures by promoting cellular health through light therapy. New Griffith University research investigated...
Bedtime can be tricky for parents, especially when their child is experiencing behavioural sleep problems, but help is on the...
The applications of Virtual Reality far exceed the gaming world as Griffith University researchers investigate its benefits for pediatric burns...
Pictured left to right: Professor Michael Good AO, PDG Sandy Doumany OAM, Associate Professor Danielle Stanisic, Her Excellency the Honourable...
A clinical trial to test the efficacy and safety of the transplantation of nasal cells to treat chronic spinal cord...
A Phase I human clinical trial is set to commence to test the efficacy and safety of the transplantation of olfactory cell nerve bridges to treat chronic spinal cord injury.
Fears for Great Barrier Reef, nuclear power and cost-of-living pressures among concerns.
A world-first trial to help improve the lives of Australians living with a debilitating spinal cord injury is a step closer with a $6.8 million Medical Research Future Fund grant.
A next-generation COVID-19 mucosal vaccine is set to be a gamechanger not only when delivering the vaccine itself, but also for people who are needle-phobic.
